End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
146.4 USD | -.--% |
|
-0.46% | -4.75% |
28/06 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
28/06 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
Official Publications
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Minutes of the general assembly | CO | |
SEC Filing 8K | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
Dividends | CO | |
Acquisition | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
SEC Filing 8K | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- News Johnson & Johnson
- Official Publications